The Food and Drug Administration on Monday granted market clearance to Stryker's cementless knee implant.
The Mako Total Knee with Triathlon Titanium implant uses the mechanics of Stryker's existing Triathlon knee implant, but contains a highly porous biologic fixation technology, which allows for a cementless solution.
"With the rise in demand for cementless knee technology, we believe this new offering can have a positive impact on procedural efficiency and patient outcomes," said Stuart Simpson, president of Stryker's joint replacement division. "We're excited to continue to lead in robotic technology and combine two of our most advanced and differentiated products to provide surgeons with the ability to transform orthopaedic surgery."
More articles on supply chain:
This biohacker is creating a recipe book of medicines patients can make at home
6 drug, devicemakers in the headlines
Roche taps drug discovery firm to develop new antibiotic classes